GANX
Gain Therapeutics Inc
1.80$
-3.3%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 60.9% | 60.3% | 93.6% | 96.8% | 87.5% | 95.5% | 95.7% | 97.5% | |
| 49.4% | 45.9% | 78.0% | 94.6% | 30.3% | 63.4% | 85.7% | 91.3% | |
| 49.4% | 45.9% | 78.0% | 94.6% | 83.6% | 90.2% | 85.7% | 91.3% | |
| 5.1% | 6.8% | 0.1% | 0.5% | 0.4% | 1.3% | 6.3% | 3.5% | |
| – | 4.8% | 14.1% | – | – | – | – | – | |
| 37.7% | 33.2% | 5.8% | 2.6% | 0.6% | – | – | – | |
| – | – | – | 0.5% | 0.9% | 1.0% | 1.1% | 0.5% | |
| 217.2% | 168.1% | 35.4% | 10.7% | 21.7% | 32.4% | 39.5% | 18.6% | |
| 65.4% | 133.1% | 22.0% | 6.5% | 17.1% | 26.6% | 32.3% | 14.7% | |
| 12.0% | 15.5% | 1.5% | 0.8% | 1.4% | 1.9% | 2.2% | 1.0% | |
| 18.4% | 23.4% | 10.0% | 1.4% | 6.7% | 7.1% | 7.8% | 3.6% | |
| – | – | 7.5% | 1.5% | 2.1% | 2.4% | 2.7% | 1.3% | |
| -117.2% | -68.1% | 64.6% | 89.3% | 78.3% | 67.6% | 60.5% | 81.4% | |
| -155.7% | -523.6% | -73.2% | -53.7% | -159.8% | -326.6% | -669.7% | -444.2% | |
| 722.0% | 1,268.0% | 123.7% | 26.1% | 49.3% | 69.9% | 188.7% | 144.5% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.